Results 191 to 200 of about 458,313 (258)

Scleritis and associated systemic diseases: contribution of systemic examination, follow-up, and additional investigations. [PDF]

J Ophthalmic Inflamm Infect
Soubrier M, Vasseneix C, Jacquot R, Bert A, Gerfaud-Valentin M, Mathis T, Kodjikian L, Sève P.   +7 more
europepmc   +1 more source

European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT). [PDF]

Orphanet J Rare Dis
Arnaud L, Sander O, Rednic S, Mertz P, Faria R, Crisafulli F, Silva-Ribeiro S, Kawka L, Sztejkowski C, Düsing C, Rose T, Lamas A, Vasconcelos C, Fontana G, Semeraro P, Neagu T, Resteu M, Damian L, Pamfil C, Bucsa C, Matthews LJ, Talarico R, Mosca M, Turchetti G, Thibault T, Devilliers H.   +25 more
europepmc   +1 more source

Trans-omics landscape of systemic vasculitis identified matrix metalloproteinase 12 as a novel signature molecule. [PDF]

Rheumatology (Oxford)
Matsumoto K, Suzuki K, Magi M, Onishi S, Yoshida H, Takeshita M, Kuramoto J, Yazawa M, Kato T, Shimizu H, Ito T, Yamada S, Sasaki E, Hanaoka K, Noguchi-Sasaki M, Matsumoto Y, Takeuchi T, Kaneko Y.   +17 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS

Arthritis & Rheumatology, 2021
Somatic mutations in UBA1 cause a newly defined syndrome known as VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome). More than 50% of patients currently identified as having VEXAS met diagnostic criteria for relapsing ...
M. Ferrada, K. Sikora, Yiming Luo, K. Wells, B. Patel, E. Groarke, Daniela Ospina Cardona, Emily Rominger, P. Hoffmann, Mimi T. Le, Z. Deng, K. Quinn, E. Rose, W. Tsai, G. Wigerblad, W. Goodspeed, Anne Jones, L. Wilson, O. Schnappauf, Ryan S Laird, Jeff Kim, C. Allen, Arlene Sirajuddin, Marcus Y. Chen, M. Gadina, K. Calvo, M. Kaplan, R. Colbert, I. Aksentijevich, N. Young, S. Savic, D. Kastner, A. Ombrello, D. Beck, P. Grayson   +34 more
semanticscholar   +1 more source

Relapsing polychondritis: Best Practice & Clinical Rheumatology.

Baillière's Best Practice & Research : Clinical Rheumatology, 2023
Relapsing polychondritis (RP) is an uncommon inflammatory disorder that predominantly targets cartilaginous structures. The disease frequently affects the nose, ears, airways, and joints, but it can also impact organs that aren't primarily cartilage ...
P. Mertz, Joshua D Sparks, Dale Kobrin, S. A. Ogbonnaya, Ecem Sevim, C. Michet, L. Arnaud, Marcela A Ferrada   +7 more
semanticscholar   +1 more source

Relapsing polychondritis - A single Centre study in the United Kingdom.

Autoimmunity Reviews, 2023
INTRODUCTION AND OBJECTIVES Relapsing Polychondritis (RP) is a rare immune mediated inflammatory disorder that may result in damage and destruction of cartilaginous tissues.
S. Sangle, C. Hughes, L. Barry, S. Qureshi, C. K. Cheah, Y. J. Poh, D. D'cruz   +6 more
semanticscholar   +1 more source

Relapsing Polychondritis

Respiration, 1998
In this article, we report on a 40-year-old man with relapsing polychondritis (RP) of the tracheobronchial tree without clinical manifestations of other systems including nasal septum and earlobe cartilage involvement. The illness was diagnosed histologically, and treatment with procaine penicillin was successful.
Yalcinkaya, I, Ozbay, B, Dilek, FH, Gencer, M   +3 more
openaire   +5 more sources

Relapsing Polychondritis

Annals of Otology, Rhinology & Laryngology, 1989
Inflammatory destruction of cartilages, presumably on an autoimmune basis, characterizes relapsing polychondritis, a disease of varying severity and outcome. The otolaryngologist–head and neck surgeon is often the first physician contact, because the preponderance of signs and symptoms are in the head and neck, ie, auricular and nasal chondritis ...
J G, Batsakis, J T, Manning
openaire   +4 more sources